WallStreetZenWallStreetZen

NASDAQ: COGT
Cogent Biosciences Inc Stock Ownership - Who owns Cogent Biosciences?

Insider buying vs selling

Have Cogent Biosciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Fairmount Funds Management LLC10% Owner2024-02-161,166,666$7.50
$8.75MBuy
Fairmount Funds Management LLC10% Owner2023-06-09800,000$12.00
$9.60MBuy

1 of 1

COGT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COGT insiders and whales buy or sell their stock.

COGT Shareholders

What type of owners hold Cogent Biosciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc6.50%6,755,584$48.84MInstitution
Kynam Capital Management LP5.63%5,854,766$42.33MInstitution
Tcg Crossover Management LLC5.42%5,631,042$40.71MInstitution
Commodore Capital LP5.36%5,566,026$40.24MInstitution
Fmr LLC5.10%5,302,854$38.34MInstitution
Point72 Asset Management LP5.00%5,191,448$37.53MInstitution
Fairmount Funds Management LLC4.55%4,725,641$34.17MInsider
Vr Adviser LLC4.51%4,684,167$33.87MInstitution
Vanguard Group Inc4.36%4,534,655$32.79MInstitution
State Street Corp3.99%4,150,615$30.01MInstitution

1 of 3

COGT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COGT87.38%11.29%Net BuyingNet Buying
PHAR0.00%0.00%
ALXO75.58%24.42%Net SellingNet Selling
CCCC68.39%25.29%Net BuyingNet Selling
NVAX55.43%19.56%Net SellingNet Selling

Cogent Biosciences Stock Ownership FAQ

Who owns Cogent Biosciences?

Cogent Biosciences (NASDAQ: COGT) is owned by 87.38% institutional shareholders, 11.29% Cogent Biosciences insiders, and 1.33% retail investors. Fairmount Funds Management LLC is the largest individual Cogent Biosciences shareholder, owning 4.73M shares representing 4.55% of the company. Fairmount Funds Management LLC's Cogent Biosciences shares are currently valued at $34.17M.

If you're new to stock investing, here's how to buy Cogent Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.